Atai Life Sciences Net Profit Margin 2020-2023 | ATAI
Atai Life Sciences net profit margin from 2020 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Atai Life Sciences Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-12-31 | $0.00B | $-0.04B | inf% |
| 2023-09-30 | $0.00B | $-0.07B | inf% |
| 2023-06-30 | $0.00B | $-0.15B | inf% |
| 2023-03-31 | $0.00B | $-0.15B | inf% |
| 2022-09-30 | $0.00B | $-0.20B | inf% |
| 2022-06-30 | $0.00B | $-0.19B | inf% |
| 2021-12-31 | $0.02B | $-0.17B | -835.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.331B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.867B | 10.20 |
| Quest Diagnostics (DGX) | United States | $15.351B | 15.86 |
| DaVita (DVA) | United States | $12.191B | 16.59 |
| Chemed (CHE) | United States | $8.599B | 26.65 |
| Encompass Health (EHC) | United States | $8.350B | 21.49 |
| Elanco Animal Health (ELAN) | United States | $6.502B | 14.79 |
| Option Care Health (OPCH) | United States | $5.195B | 19.66 |
| RadNet (RDNT) | United States | $3.584B | 97.00 |
| Amedisys (AMED) | United States | $3.008B | 21.31 |
| LifeStance Health (LFST) | United States | $2.362B | 0.00 |
| Astrana Health (ASTH) | United States | $2.081B | 25.98 |
| Addus HomeCare (ADUS) | United States | $1.574B | 23.92 |
| U.S Physical Therapy (USPH) | United States | $1.530B | 39.65 |
| Pennant (PNTG) | United States | $0.628B | 36.68 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.433B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.027B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.018B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.013B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.012B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |